who_better_than_me
Time to go!!
Yeah this month. Back in December in the 24th they said it would take roughly 45 days to uplist. That would be February 8th. Shareholders meeting is on Friday so an uplist can potentially happened Monday
Boiler Room: The Official Stock Market Discussion
who_better_than_me
Time to go!!
I cut it in half to take profit. Down to 380. was about 800.
I gotta get in on this while it’s cheap. I bet u have 100s of shares
It hit 4.90 before and I took profit around 4.75. Got back in when it dipped to around 3
That’s good u should get a initial boost when they’re listed
who_better_than_me
Time to go!!
Already have a boost. With my reentry I’m already up a couple bands. It’s up 2 dollars in the last two weeks
No doubt thanks to Reddit and YouTube. Hopefully for me it goes down some by Friday
I been asking this shyt for the longestthe hell does ebay do at this point to still be sticking around & doing well?
QCOM raised guidance then missed...good time for me to add to my position, down $15 in AH
who_better_than_me
Time to go!!
It’s otc so it doesn’t have a lot of exposure. The uplisting will get them that webull and rh exposure
Last edited:
Akebia Therapeutics has been running for me lately: AKBA. It's up from 3.12 to 3.95 and it's up in after hours. Pure novice here but I've been doing my research.
They have a treatment, Vadadustat, for anemia due to chronic kidney disease which isn't FDA approved yet, but a study in Texas received funding from the DOD. They were up at $10 before but while Vadadustat seemed to work it didn't meet safety regulations so it wasn't FDA approved. They're trying again to get approved in the USA. They were approved to go ahead in Japan in June, but the FDA is more stringent than most foreign country's regulating bodies.
Akebia Therapeutics' Vadadustat' COVID-19 trial at University of Texas Health Science Center gets DOD funding (NASDAQ:AKBA) | Seeking Alpha
Why Akebia Therapeutics Stock Is Crashing Today (fool.com)
They have a treatment, Vadadustat, for anemia due to chronic kidney disease which isn't FDA approved yet, but a study in Texas received funding from the DOD. They were up at $10 before but while Vadadustat seemed to work it didn't meet safety regulations so it wasn't FDA approved. They're trying again to get approved in the USA. They were approved to go ahead in Japan in June, but the FDA is more stringent than most foreign country's regulating bodies.
Akebia Therapeutics' Vadadustat' COVID-19 trial at University of Texas Health Science Center gets DOD funding (NASDAQ:AKBA) | Seeking Alpha
Why Akebia Therapeutics Stock Is Crashing Today (fool.com)
Chamath’s last tweet was cryptic.
-Klein through shade at him indirectly on a call saying they’re focused on quality deals, not like others that are just trying to get as many deals as possible done (this could be a reach, but sure sounded like it was directed at Chamath)
-Chamath has a history of snatching targets from competitors (PSTH/Ackman were linked to SoFi before Chamath swooped in)
-Tweeted this when the Visa/Plaid deal fell through
-Chamath knows what investors have an appetite for. This is a guy who bought GME options on a whim. He’s aware of how sexy of a target Lucid is and it fits in with his thesis of “trying to change the world for the better” since it’s an EV play
don’t know if IPOF is big enough though. Would likely need a large PIPE (pause) as well. Seems highly unlikely and this is all speculation, but wouldn’t put it past Chamath
-Klein through shade at him indirectly on a call saying they’re focused on quality deals, not like others that are just trying to get as many deals as possible done (this could be a reach, but sure sounded like it was directed at Chamath)
-Chamath has a history of snatching targets from competitors (PSTH/Ackman were linked to SoFi before Chamath swooped in)
-Tweeted this when the Visa/Plaid deal fell through
-Chamath knows what investors have an appetite for. This is a guy who bought GME options on a whim. He’s aware of how sexy of a target Lucid is and it fits in with his thesis of “trying to change the world for the better” since it’s an EV play
don’t know if IPOF is big enough though. Would likely need a large PIPE (pause) as well. Seems highly unlikely and this is all speculation, but wouldn’t put it past Chamath
Whats ur rationale. Im curious cuz Im currently looking for more long term plays in my port
I’m curious about this. Sofi is almost a full service online banking institution that also has investing capabilities and does student loans. I like clover as well but why do you think sofi is secondary? I think both are strong entities going forward.